We held Pfizer to account for misleading parents about the safety of it Covid vaccine product for children by submitting a complaint to the UK medicines regulator, the Prescription Medicines Code of Practice Authority (PMCPA).

The complaint cited the overtly promotional nature of a BBC interview with the Global Chairman and Chief Executive of Pfizer, Dr Albert Bourla. In the interview Dr Bourla made misleading and unbalanced promotional comments about his company’s product which went unchallenged by the BBC, and which contravened the strict rules governing the promotion of medicines in the UK.

A key decision by an industry-appointed appeal board affirmed the PMCPA’s original findings that Dr Bourla’s comments on the topic of vaccinating 5- to 11-year-olds were promotional in nature, and were both misleading and incapable of substantiation in relation to matters of safety.